2-oxo-3-hydroxy-LSD: An important LSD metabolite?

Citation
Ag. Verstraete et Ej. Van De Velde, 2-oxo-3-hydroxy-LSD: An important LSD metabolite?, ACT CLIN B, 1999, pp. 94-96
Citations number
6
Categorie Soggetti
General & Internal Medicine
Journal title
ACTA CLINICA BELGICA
ISSN journal
00015512 → ACNP
Year of publication
1999
Supplement
1
Pages
94 - 96
Database
ISI
SICI code
0001-5512(1999):<94:2AILM>2.0.ZU;2-V
Abstract
Recently, certain studies have indicated that 2-oxo-3-hydroxy-LSD is presen t in urine at much higher concentrations than LSD. We determined LSD and 2- oxo-3-hydroxy-LSD in urine by CC-MS (Hewlett Packard 5970) after solid phas e extraction on SPEC.PLUS MP1 disks (3 mL, 30 mg, Ansys, Irvine, CA, USA), using the method recommended for amphetamines and derivatisation with BSTFA . For 2-oxo-3-hydroxy-LSD-bis-TMS, the ions with m/z of 309 and 499 were us ed as quantification and confirmation ion respectively. In four samples containing between 561 and 7007 pg/mL of LSD, 2-oxo-3-hydro xy-LSD concentrations between 8021 and 28466 pg/mL were found, i.e. 4 to 41 times higher than the LSD concentrations. 2-oxo-3-hydroxy-LSD does not see m to be conjugated. These results indicate that 2-oxo-3-hydroxy-LSD is pres ent in urine in much higher concentrations than LSD, which could facilitate confirmation of positive screenings and increase detection times.